文献速递外周动脉疾病

糖尿病状态影响肾功能不全与外周动脉疾病腔内治疗结局的关联

Different association between renal dysfunction and clinical outcomes according to the presence of diabetes in patients undergoing endovascular treatment for peripheral artery disease.
PubMed 文献 · J Vasc Surg · 2019-07-05

本研究基于韩国多中心EVT注册数据,按糖尿病状态分层后比较合并与不合并CKD患者下肢EVT后2年MALE风险。结果显示CKD仅在糖尿病患者中与MALE风险显著升高相关,非糖尿病患者中无此关联,且该风险主要由终末期肾病患者驱动。

要点

  • 糖尿病患者合并CKD时EVT后2年MALE风险显著升高(14.4% vs 9.9%,aHR 1.60)。
  • 糖尿病合并CKD者MALE风险升高主要见于终末期肾病患者。

核心结论

  • 糖尿病患者合并CKD时下肢EVT后MALE风险显著升高,非糖尿病患者中未见此关联。

研究设计与样本

  • 基于韩国多中心EVT注册研究,共纳入3045例患者,按糖尿病和CKD(eGFR<60 mL/min/1.73 m2)分层分析。

主要发现

  • 糖尿病患者中CKD与MALE风险显著升高相关(14.4% vs 9.9%;aHR 1.60;95%CI 1.28-2.01;P<.001)。
  • 非糖尿病患者中CKD与MALE风险无显著关联(7.6% vs 9.7%;aHR 0.78;95%CI 0.53-1.14;P=.203;交互P=.018)。
  • 糖尿病患者中按CKD严重程度分层,终末期肾病与MALE风险升高显著相关。

临床怎么用

  • 对接受下肢EVT的糖尿病患者应重视合并CKD尤其是终末期肾病者的MALE风险。
  • 非糖尿病患者合并CKD时EVT后MALE风险未见显著增加。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Although chronic kidney disease (CKD) and diabetes are important prognostic factors in patients with peripheral artery disease, there are limited data regarding the outcomes of endovascular treatment (EVT) according to the severity of CKD, especially in the presence of diabetes. This study sought to compare clinical outcomes of lower limb EVT between patients with and patients without CKD according to the presence of diabetes. METHODS: Patients were enrolled from the Korean multicenter EVT registry and were divided according to the presence of diabetes, then further stratified by CKD (estimated glomerular filtration rate <60 mL/min/1.73 m2). The primary outcome was major adverse limb events (MALEs; a composite of reintervention for target limb, reintervention for target vessel, and unplanned major amputation) at 2 years. RESULTS: A total of 3045 patients were eligible for analysis: 1277 nondiabetic patients (944 without CKD, 333 with CKD) and 1768 diabetic patients (951 without CKD, 817 with CKD). CKD was associated with a significantly increased risk of MALEs after EVT in diabetic patients (14.4% vs 9.9%; adjusted hazard ratio, 1.60; 95% confidence interval, 1.28-2.01; P < .001) but not in nondiabetic patients (7.6% vs 9.7%; adjusted hazard ratio, 0.78; 95% confidence interval, 0.53-1.14; P = .203; interaction P = .018). In analysis stratified by the severity of CKD among diabetic patients, end-stage renal disease was significantly associated with an increased risk of MALE. CONCLUSIONS: CKD was associated with a significantly higher risk of MALEs after EVT in diabetic patients but not in nondiabetic patients. The increased risk of MALEs was mainly driven by patients with end-stage renal disease.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Kim J, Park TK, Choi KH, et al. Different association between renal dysfunction and clinical outcomes according to the presence of diabetes in patients undergoing endovascular treatment for peripheral artery disease. J Vasc Surg. 2019. PMID: 31285068. doi:10.1016/j.jvs.2019.03.071

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。